Literature DB >> 21629610

Risk of coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in Nova Scotia.

Kevin R Forward1.   

Abstract

BACKGROUND: The frequency of Chlamydia trachomatis and Neisseria gonorrhoeae coinfection can vary depending on their individual incidence and prevalence rates.
OBJECTIVE: To determine the frequency of C trachomatis and N gonorrhoeae coinfections by evaluating the results of testing in 2007 and 2008 to better inform testing and treatment decisions.
METHODS: Specimens from the same patient submitted on the same day served as the basis for the present study. The age, sex and the source of the specimen were also linked to the accession number. Infection and coinfection rates were analyzed in both males and females.
RESULTS: Concurrent testing was performed on 41,567 female specimens and 1827 male specimens, of which, 1495 female samples (3.6%) tested positive for C trachomatis infection and 88 (0.2%) tested positive for N gonorrhoeae infections. Only 31 females were coinfected; however, for those between 11 and 25 years of age, 25 of 61 females (40.1%) with N gonorrhoeae infection also tested positive for C trachomatis infection; conversely, 25 of 1248 females (2.0%) with C trachomatis infection also tested positive for N gonorrhoeae infection. For males, 213 (11.7%) tested positive for C trachomatis infection, and 59 (3.2%) tested positive for N gonorrhoeae infection. In 30 males with N gonorrhoeae between 11 and 25 years of age, and 149 males with C trachomatis, eight coinfections were observed (26.7% and 5.3%, respectively). Of those older than 25 years of age, only five of 905 men and six of 19,465 women were coinfected. None of the 10,935 women who were 30 years of age or older had coinfections.
CONCLUSION: The N gonorrhoeae coinfection rate in males with C trachomatis may justify empirical antimicrobials; however, in females, the proportion of coinfected may not justify empirical treatment for N gonorrhoeae infection when the C trachomatis test is positive and N gonorrhoeae testing has not been performed.

Entities:  

Keywords:  Chlamydia trachomatis; Coinfection; Neisseria gonorrhoeae

Year:  2010        PMID: 21629610      PMCID: PMC2912101          DOI: 10.1155/2010/760218

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN: 1712-9532            Impact factor:   2.471


  6 in total

1.  The frequency of co-infection with Neisseria gonorrhoeae and Chlamydia trachomatis in men and women in eastern Sydney.

Authors:  J W Tapsall; M Kinchington
Journal:  Pathology       Date:  1996-01       Impact factor: 5.306

2.  Co-infection with gonorrhoea and chlamydia: how much is there and what does it mean?

Authors:  Sarah Creighton; Melinda Tenant-Flowers; Christopher B Taylor; Rob Miller; Nicola Low
Journal:  Int J STD AIDS       Date:  2003-02       Impact factor: 1.359

3.  Concurrent gonococcal and chlamydial infections among men attending a sexually transmitted diseases clinic.

Authors:  A McMillan; K Manavi; H Young
Journal:  Int J STD AIDS       Date:  2005-05       Impact factor: 1.359

4.  Chlamydia trachomatis among patients infected with and treated for Neisseria gonorrhoeae in sexually transmitted disease clinics in the United States.

Authors:  Sheryl B Lyss; Mary L Kamb; Thomas A Peterman; John S Moran; Daniel R Newman; Gail Bolan; John M Douglas; Michael Iatesta; C Kevin Malotte; Jonathan M Zenilman; Josephine Ehret; Charlotte Gaydos; Wilbert J Newhall
Journal:  Ann Intern Med       Date:  2003-08-05       Impact factor: 25.391

5.  Chlamydia and gonorrhea co-occurrence in a high school population.

Authors:  Malanda Nsuami; Catherine L Cammarata; Bridget N Brooks; Stephanie N Taylor; David H Martin
Journal:  Sex Transm Dis       Date:  2004-07       Impact factor: 2.830

6.  Population prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae in the Netherlands. Should asymptomatic persons be tested during population-based Chlamydia screening also for gonorrhoea or only if chlamydial infection is found?

Authors:  Jan E A M van Bergen; Joke Spaargaren; Hannelore M Götz; Irene K Veldhuijzen; Patrick J E Bindels; Ton J Coenen; Jan Broer; Fetzen de Groot; Christian J P A Hoebe; Jan-Hendrik Richardus; Daniel van Schaik; Marije Verhooren
Journal:  BMC Infect Dis       Date:  2006-03-07       Impact factor: 3.090

  6 in total
  9 in total

1.  Discovery of Blood Transcriptional Endotypes in Women with Pelvic Inflammatory Disease.

Authors:  Xiaojing Zheng; Catherine M O'Connell; Wujuan Zhong; Uma M Nagarajan; Manoj Tripathy; De'Ashia Lee; Ali N Russell; Harold Wiesenfeld; Sharon Hillier; Toni Darville
Journal:  J Immunol       Date:  2018-03-12       Impact factor: 5.422

2.  Aptima Combo 2 testing detected additional cases of Neisseria gonorrhoeae infection in men and women in community settings.

Authors:  Julius Kapala; Kathy Biers; Michael Cox; Margaret Kamionka; Jeff Sumner; Ramandeep Toor; Jodi Gilchrist; Dan Jang; Marek Smieja; Max Chernesky
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

3.  High prevalence of asymptomatic sexually transmitted infections among human immunodeficiency virus-infected pregnant women in a low-income South African community.

Authors:  Maanda Mudau; Remco P Peters; Lindsey De Vos; Dawie H Olivier; Dvora J Davey; Edwin S Mkwanazi; James A McIntyre; Jeffrey D Klausner; Andrew Medina-Marino
Journal:  Int J STD AIDS       Date:  2017-08-11       Impact factor: 1.359

4.  Complement alone drives efficacy of a chimeric antigonococcal monoclonal antibody.

Authors:  Sunita Gulati; Frank J Beurskens; Bart-Jan de Kreuk; Marcel Roza; Bo Zheng; Rosane B DeOliveira; Jutamas Shaughnessy; Nancy A Nowak; Ronald P Taylor; Marina Botto; Xianbao He; Robin R Ingalls; Trent M Woodruff; Wen-Chao Song; Janine Schuurman; Peter A Rice; Sanjay Ram
Journal:  PLoS Biol       Date:  2019-06-19       Impact factor: 8.029

5.  Preclinical Efficacy of a Lipooligosaccharide Peptide Mimic Candidate Gonococcal Vaccine.

Authors:  Sunita Gulati; Michael W Pennington; Andrzej Czerwinski; Darrick Carter; Bo Zheng; Nancy A Nowak; Rosane B DeOliveira; Jutamas Shaughnessy; George W Reed; Sanjay Ram; Peter A Rice
Journal:  mBio       Date:  2019-11-05       Impact factor: 7.867

6.  Recommendation on screening for chlamydia and gonorrhea in primary care for individuals not known to be at high risk.

Authors:  Ainsley Moore; Gregory Traversy; Donna L Reynolds; John J Riva; Guylène Thériault; Brenda J Wilson; Melissa Subnath; Brett D Thombs
Journal:  CMAJ       Date:  2021-04-19       Impact factor: 8.262

7.  Screening for chlamydia and/or gonorrhea in primary health care: systematic reviews on effectiveness and patient preferences.

Authors:  Jennifer Pillay; Aireen Wingert; Tara MacGregor; Michelle Gates; Ben Vandermeer; Lisa Hartling
Journal:  Syst Rev       Date:  2021-04-19

Review 8.  Coinfection of Chlamydiae and other Bacteria in Reactive Arthritis and Spondyloarthritis: Need for Future Research.

Authors:  Henning Zeidler; Alan P Hudson
Journal:  Microorganisms       Date:  2016-08-24

9.  Hyperendemic Chlamydia trachomatis sexually transmitted infections among females represent a high burden of asymptomatic disease and health disparity among Pacific Islanders in Fiji.

Authors:  Virginia Svigals; Alden Blair; Santha Muller; Aalisha Sahu Khan; Daniel Faktaufon; Mike Kama; Torika Tamani; Laila Esfandiari; Mollie O'Brien; Deborah Dean
Journal:  PLoS Negl Trop Dis       Date:  2020-01-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.